Method: A cross-sectional retrospective prevalence study which employed self-weighted character 100% sampling method was used. All eligible 308 records at the 9 diagnostic Centers were included.

Results: The proportion of new TB cases that had resistance to first-line anti-tuberculosis was 10.7%, while primary resistance =8.3%.and secondary resistance 2.6%, Rifampicin resistant at 2.3. %, by gender 104/308 men and women 226/308 between 22 to 30years, further non-evaluation of treatment outcomes at 39.6%., cure rate   42.56%, The comorbidity was at 42.3%.

Conclusion: The proportion of new TB cases, primary, Rifampicin and previously treated cases resistant to first-line anti-tuberculosis, non-evaluation of treatment outcomes and comorbidity was significantly high, while the Cure rate was drastically low.